The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Immune Cells and Immunotherapy for Cardiac Injury and Repair
Open accessAbstract
Cardiac injury remains a major cause of morbidity and mortality worldwide. Despite significant advances, a full understanding of why the heart fails to fully recover function after acute injury, and why progressive heart failure frequently ensues, remains elusive. No therapeutics, short of heart transplantation, have emerged to reliably halt or reverse the inexorable progression of heart failure in the majority of patients once it has become clinically evident. To date, most pharmacological interventions have focused on modifying hemodynamics (reducing afterload, controlling blood pressure and blood volume) or on modifying cardiac myocyte function. However, important contributions of the immune system to normal cardiac function and the response to injury have recently emerged as exciting areas of investigation. Therapeutic interventions aimed at harnessing the power of immune cells hold promise for new treatment avenues for cardiac disease. Here, we review the immune response to heart injury, its contribution to cardiac fibrosis, and the potential of immune modifying therapies to affect cardiac repair.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Lee, D. W., Santomasso, B. D., Locke, F. L., Ghobadi, A., Turtle, C. J., Brudno, J. N., Maus, M. V., Park, J. H., Mead, E., Pavletic, S., et al. (2019) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2018.12.758 · Cited by 3,675
Fajgenbaum, D. C., & June, C. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2026131 · Cited by 3,196
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582
Kalos, M., Levine, B. L., Porter, D. L., Katz, S., Grupp, S. A., Bagg, A., & June, C. H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002842 · Cited by 2,388
Molecular mechanisms and cellular functions of cGAS–STING signalling
Hopfner, K.-P., & Hornung, V. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0244-x · Cited by 2,052
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
Nishimura, H., Okazaki, T., Tanaka, Y., Nakatani, K., Hara, M., Matsumori, A., Sasayama, S., Mizoguchi, A., Hiai, H., Minato, N., et al. (2001) · Science · doi:10.1126/science.291.5502.319 · Cited by 1,868
Cells of the adult human heart
Litviňuková, M., Talavera-López, C., Maatz, H., Reichart, D., Worth, C. L., Lindberg, E. L., Kanda, M., Polanski, K., Heinig, M., Lee, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2797-4 · Cited by 1,729
Eshhar, Z., Waks, T., Gross, G., & Schindler, D. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.720 · Cited by 1,658
Human chimeric antigen receptor macrophages for cancer immunotherapy
Klichinsky, M., Ruella, M., Shestova, O., Lu, X. M., Best, A., Zeeman, M., Schmierer, M., Gabrusiewicz, K., Anderson, N. R., Petty, N. E., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0462-y · Cited by 1,495
Epelman, S., Lavine, K. J., Beaudin, A. E., Sojka, D. K., Carrero, J. A., Calderon, B., Brija, T., Gautier, E. L., Ivanov, S., Satpathy, A. T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.11.019 · Cited by 1,494
Targeting the TGFβ signalling pathway in disease
Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466
Molecular Mechanisms of Myocardial Remodeling
SWYNGHEDAUW, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.215 · Cited by 1,460
Zannad, F., Ferreira, J. P., Pocock, S. J., Anker, S. D., Butler, J., Filippatos, G., Brueckmann, M., Ofstad, A. P., Pfarr, E., Jamal, W., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31824-9 · Cited by 1,408
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
Ridker, P. M., Everett, B. M., Pradhan, A., MacFadyen, J. G., Solomon, D. H., Zaharris, E., Mam, V., Hasan, A., Rosenberg, Y., Iturriaga, E., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1809798 · Cited by 1,317
Askari, A. T., Unzek, S., Popovic, Z. B., Goldman, C. K., Forudi, F., Kiedrowski, M., Rovner, A., Ellis, S. G., Thomas, J. D., DiCorleto, P. E., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14232-8 · Cited by 1,270
Mann, D. L., McMurray, J. J. V., Packer, M., Swedberg, K., Borer, J. S., Colucci, W. S., Djian, J., Drexler, H., Feldman, A., Kober, L., et al. (2004) · Circulation · doi:10.1161/01.cir.0000124490.27666.b2 · Cited by 1,240
A Special Population of Regulatory T Cells Potentiates Muscle Repair
Burzyn, D., Kuswanto, W., Kolodin, D., Shadrach, J. L., Cerletti, M., Jang, Y., Sefik, E., Tan, T. G., Wagers, A. J., Benoist, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.054 · Cited by 1,234
Linette, G. P., Stadtmauer, E. A., Maus, M. V., Rapoport, A. P., Levine, B. L., Emery, L., Litzky, L., Bagg, A., Carreno, B. M., Cimino, P. J., et al. (2013) · Blood · doi:10.1182/blood-2013-03-490565 · Cited by 1,179
Rooney, C. M., Ng, C. Y. C., Loftin, S., Smith, C. A., Li, C., Krance, R. A., Brenner, M. K., Heslop, H. E., Rooney, C. M., Brenner, M. K., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91150-2 · Cited by 1,173
Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy
Assomull, R. G., Prasad, S. K., Lyne, J., Smith, G., Burman, E. D., Khan, M., Sheppard, M. N., Poole-Wilson, P. A., & Pennell, D. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.049 · Cited by 1,164
Biology and therapeutic potential of interleukin-10
Saraiva, M., Vieira, P., & O’Garra, A. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190418 · Cited by 1,118
Senolytic CAR T cells reverse senescence-associated pathologies
Amor, C., Feucht, J., Leibold, J., Ho, Y.-J., Zhu, C., Alonso-Curbelo, D., Mansilla-Soto, J., Boyer, J. A., Li, X., Giavridis, T., et al. (2020) · Nature · doi:10.1038/s41586-020-2403-9 · Cited by 1,098
Macrophages Facilitate Electrical Conduction in the Heart
Hulsmans, M., Clauss, S., Xiao, L., Aguirre, A. D., King, K. R., Hanley, A., Hucker, W. J., Wülfers, E. M., Seemann, G., Courties, G., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.050 · Cited by 1,011
Distinct fibroblast subsets drive inflammation and damage in arthritis
Croft, A. P., Campos, J., Jansen, K., Turner, J. D., Marshall, J., Attar, M., Savary, L., Wehmeyer, C., Naylor, A. J., Kemble, S., et al. (2019) · Nature · doi:10.1038/s41586-019-1263-7 · Cited by 976
Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
Khalil, H., Kanisicak, O., Prasad, V., Correll, R. N., Fu, X., Schips, T., Vagnozzi, R. J., Liu, R., Huynh, T., Lee, S.-J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94753 · Cited by 905
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892
Receptor-associated Mad homologues synergize as effectors of the TGF-β response
Zhang, Y., Feng, X.-H., Wu, R.-Y., & Derynck, R. (1996) · Nature · doi:10.1038/383168a0 · Cited by 872
Kloss, C. C., Condomines, M., Cartellieri, M., Bachmann, M., & Sadelain, M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2459 · Cited by 857
Cardioimmunology: the immune system in cardiac homeostasis and disease
Swirski, F. K., & Nahrendorf, M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0065-8 · Cited by 849
Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Frangogiannis, N. G. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.001 · Cited by 841
Bozkurt, B., Kribbs, S. B., Clubb, F. J., Michael, L. H., Didenko, V. V., Hornsby, P. J., Seta, Y., Oral, H., Spinale, F. G., & Mann, D. L. (1998) · Circulation · doi:10.1161/01.cir.97.14.1382 · Cited by 821
Lavine, K. J., Epelman, S., Uchida, K., Weber, K. J., Nichols, C. G., Schilling, J. D., Ornitz, D. M., Randolph, G. J., & Mann, D. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406508111 · Cited by 818
Targeting cardiac fibrosis with engineered T cells
Aghajanian, H., Kimura, T., Rurik, J. G., Hancock, A. S., Leibowitz, M. S., Li, L., Scholler, J., Monslow, J., Lo, A., Han, W., et al. (2019) · Nature · doi:10.1038/s41586-019-1546-z · Cited by 801
Self-citationA Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts
Loktev, A., Lindner, T., Mier, W., Debus, J., Altmann, A., Jäger, D., Giesel, F., Kratochwil, C., Barthe, P., Roumestand, C., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.210435 · Cited by 777
Promoting tissue regeneration by modulating the immune system
Julier, Z., Park, A. J., Briquez, P. S., & Martino, M. M. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.056 · Cited by 766
A Network of Macrophages Supports Mitochondrial Homeostasis in the Heart
Nicolás-Ávila, J. A., Lechuga-Vieco, A. V., Esteban-Martínez, L., Sánchez-Díaz, M., Díaz-García, E., Santiago, D. J., Rubio-Ponce, A., Li, J. L., Balachander, A., Quintana, J. A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.031 · Cited by 762
Bajpai, G., Bredemeyer, A., Li, W., Zaitsev, K., Koenig, A. L., Lokshina, I., Mohan, J., Ivey, B., Hsiao, H.-M., Weinheimer, C., et al. (2019) · Circulation Research · doi:10.1161/circresaha.118.314028 · Cited by 751
Horckmans, M., Ring, L., Duchene, J., Santovito, D., Schloss, M. J., Drechsler, M., Weber, C., Soehnlein, O., & Steffens, S. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw002 · Cited by 727
Weirather, J., Hofmann, U. D. W., Beyersdorf, N., Ramos, G. C., Vogel, B., Frey, A., Ertl, G., Kerkau, T., & Frantz, S. (2014) · Circulation Research · doi:10.1161/circresaha.115.303895 · Cited by 699
Innate Immunity and the Failing Heart: The Cytokine Hypothesis Revisited
Mann, D. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.302317 · Cited by 689
Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury
Vinten-Johansen, J. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.10.011 · Cited by 680
Advances in Experimental Medicine and Biology
Berry, C. L. (1973) · Journal of Medical Genetics · doi:10.1136/jmg.10.4.401-a · Cited by 661
Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure
Everett, B. M., Cornel, J. H., Lainscak, M., Anker, S. D., Abbate, A., Thuren, T., Libby, P., Glynn, R. J., & Ridker, P. M. (2019) · Circulation · doi:10.1161/circulationaha.118.038010 · Cited by 658
Wang, L.-C. S., Lo, A., Scholler, J., Sun, J., Majumdar, R. S., Kapoor, V., Antzis, M., Cotner, C. E., Johnson, L. A., Durham, A. C., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0027 · Cited by 653
T cell-engaging therapies — BiTEs and beyond
Goebeler, M.-E., & Bargou, R. C. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0347-5 · Cited by 644
The extracellular matrix protein agrin promotes heart regeneration in mice
Bassat, E., Mutlak, Y. E., Genzelinakh, A., Shadrin, I. Y., Baruch Umansky, K., Yifa, O., Kain, D., Rajchman, D., Leach, J., Riabov Bassat, D., et al. (2017) · Nature · doi:10.1038/nature22978 · Cited by 642
IL-11 is a crucial determinant of cardiovascular fibrosis
Schafer, S., Viswanathan, S., Widjaja, A. A., Lim, W.-W., Moreno-Moral, A., DeLaughter, D. M., Ng, B., Patone, G., Chow, K., Khin, E., et al. (2017) · Nature · doi:10.1038/nature24676 · Cited by 639
Engineering CAR-T Cells for Next-Generation Cancer Therapy
Hong, M., Clubb, J. D., & Chen, Y. Y. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.07.005 · Cited by 639
Resident fibroblast lineages mediate pressure overload–induced cardiac fibrosis
Moore-Morris, T., Guimarães-Camboa, N., Banerjee, I., Zambon, A. C., Kisseleva, T., Velayoudon, A., Stallcup, W. B., Gu, Y., Dalton, N. D., Cedenilla, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74783 · Cited by 630
Maher, T. M., Corte, T. J., Fischer, A., Kreuter, M., Lederer, D. J., Molina-Molina, M., Axmann, J., Kirchgaessler, K.-U., Samara, K., Gilberg, F., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30341-8 · Cited by 629
An introduction to chimeric antigen receptor (CAR) T‐cell immunotherapy for human cancer
Feins, S., Kong, W., Williams, E. F., Milone, M. C., & Fraietta, J. A. (2019) · American Journal of Hematology · doi:10.1002/ajh.25418 · Cited by 614
Cardiac monocytes and macrophages after myocardial infarction
Peet, C., Ivetic, A., Bromage, D. I., & Shah, A. M. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvz336 · Cited by 600
Association Between Hospitalization for Pneumonia and Subsequent Risk of Cardiovascular Disease
Corrales-Medina, V. F., Alvarez, K. N., Weissfeld, L. A., Angus, D. C., Chirinos, J. A., Chang, C.-C. H., Newman, A., Loehr, L., Folsom, A. R., Elkind, M. S., et al. (2015) · JAMA · doi:10.1001/jama.2014.18229 · Cited by 591
The role of fibroblast activation protein in health and malignancy
Fitzgerald, A. A., & Weiner, L. M. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09909-3 · Cited by 589
Skelly, D. A., Squiers, G. T., McLellan, M. A., Bolisetty, M. T., Robson, P., Rosenthal, N. A., & Pinto, A. R. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.072 · Cited by 560
Hilgendorf, I., Gerhardt, L. M. S., Tan, T. C., Winter, C., Holderried, T. A. W., Chousterman, B. G., Iwamoto, Y., Liao, R., Zirlik, A., Scherer-Crosbie, M., et al. (2014) · Circulation Research · doi:10.1161/circresaha.114.303204 · Cited by 559
Transcriptional and Cellular Diversity of the Human Heart
Tucker, N. R., Chaffin, M., Fleming, S. J., Hall, A. W., Parsons, V. A., Bedi, K. C., Akkad, A.-D., Herndon, C. N., Arduini, A., Papangeli, I., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.045401 · Cited by 554
An acute immune response underlies the benefit of cardiac stem cell therapy
Vagnozzi, R. J., Maillet, M., Sargent, M. A., Khalil, H., Johansen, A. K. Z., Schwanekamp, J. A., York, A. J., Huang, V., Nahrendorf, M., Sadayappan, S., et al. (2020) · Nature · doi:10.1038/s41586-019-1802-2 · Cited by 554
Dobaczewski, M., Gonzalez-Quesada, C., & Frangogiannis, N. G. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.07.015 · Cited by 548
DC isoketal-modified proteins activate T cells and promote hypertension
Kirabo, A., Fontana, V., de Faria, A. P. C., Loperena, R., Galindo, C. L., Wu, J., Bikineyeva, A. T., Dikalov, S., Xiao, L., Chen, W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74084 · Cited by 538
Kim, S. R., Lee, S.-G., Kim, S. H., Kim, J. H., Choi, E., Cho, W., Rim, J. H., Hwang, I., Lee, C. J., Lee, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15983-6 · Cited by 536
The Extracellular Matrix in Ischemic and Nonischemic Heart Failure
Frangogiannis, N. G. (2019) · Circulation Research · doi:10.1161/circresaha.119.311148 · Cited by 520
Adult mouse epicardium modulates myocardial injury by secreting paracrine factors
Zhou, B., Honor, L. B., He, H., Ma, Q., Oh, J.-H., Butterfield, C., Lin, R.-Z., Melero-Martin, J. M., Dolmatova, E., Duffy, H. S., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45529 · Cited by 517
Hamson, E. J., Keane, F. M., Tholen, S., Schilling, O., & Gorrell, M. D. (2014) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201300095 · Cited by 496
Molecular and Cellular Mechanisms of Atrial Fibrosis in Atrial Fibrillation
Nattel, S. (2017) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2017.03.002 · Cited by 491
Dorsheimer, L., Assmus, B., Rasper, T., Ortmann, C. A., Ecke, A., Abou-El-Ardat, K., Schmid, T., Brüne, B., Wagner, S., Serve, H., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2018.3965 · Cited by 470
Tran, E., Chinnasamy, D., Yu, Z., Morgan, R. A., Lee, C.-C. R., Restifo, N. P., & Rosenberg, S. A. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130110 · Cited by 463
Periostin is essential for cardiac healingafter acute myocardial infarction
Shimazaki, M., Nakamura, K., Kii, I., Kashima, T., Amizuka, N., Li, M., Saito, M., Fukuda, K., Nishiyama, T., Kitajima, S., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071297 · Cited by 461
Parker, K. R., Migliorini, D., Perkey, E., Yost, K. E., Bhaduri, A., Bagga, P., Haris, M., Wilson, N. E., Liu, F., Gabunia, K., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.022 · Cited by 455
Teekakirikul, P., Eminaga, S., Toka, O., Alcalai, R., Wang, L., Wakimoto, H., Nayor, M., Konno, T., Gorham, J. M., Wolf, C. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42028 · Cited by 448
Denton (2007) · doi:10.1002/art.22289 · Cited by 447
Targeting cardiovascular inflammation: next steps in clinical translation
Lawler, P. R., Bhatt, D. L., Godoy, L. C., Lüscher, T. F., Bonow, R. O., Verma, S., & Ridker, P. M. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa099 · Cited by 443
Kuwana, Y., Asakura, Y., Utsunomiya, N., Nakanishi, M., Arata, Y., Itoh, S., Nagase, F., & Kurosawa, Y. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90502-x · Cited by 429
Abbate, A., Kontos, M. C., Grizzard, J. D., Biondi-Zoccai, G. G. L., Van Tassell, B. W., Robati, R., Roach, L. M., Arena, R. A., Roberts, C. S., Varma, A., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.12.059 · Cited by 415
Ma, Y., Mouton, A. J., & Lindsey, M. L. (2018) · Translational Research · doi:10.1016/j.trsl.2017.10.001 · Cited by 405
Vakeva, A. P., Agah, A., Rollins, S. A., Matis, L. A., Li, L., & Stahl, G. L. (1998) · Circulation · doi:10.1161/01.cir.97.22.2259 · Cited by 399
Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics
Puré, E., & Blomberg, R. (2018) · Oncogene · doi:10.1038/s41388-018-0275-3 · Cited by 391
Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease
Jaiswal, S., & Libby, P. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0247-5 · Cited by 386
Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv
Thomas, T. C., Rollins, S. A., Rother, R. P., Giannoni, M. A., Hartman, S. L., Elliott, E. A., Nye, S. H., Matis, L. A., Squinto, S. P., & Evans, M. J. (1996) · Molecular Immunology · doi:10.1016/s0161-5890(96)00078-8 · Cited by 363
Abbate, A., Salloum, F. N., Vecile, E., Das, A., Hoke, N. N., Straino, S., Biondi-Zoccai, G. G. L., Houser, J.-E., Qureshi, I. Z., Ownby, E. D., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.740233 · Cited by 360
Essential Role of Smad3 in Infarct Healing and in the Pathogenesis of Cardiac Remodeling
Bujak, M., Ren, G., Kweon, H. J., Dobaczewski, M., Reddy, A., Taffet, G., Wang, X.-F., & Frangogiannis, N. G. (2007) · Circulation · doi:10.1161/circulationaha.107.704197 · Cited by 356
Alternatively activated macrophages determine repair of the infarcted adult murine heart
Shiraishi, M., Shintani, Y., Shintani, Y., Ishida, H., Saba, R., Yamaguchi, A., Adachi, H., Yashiro, K., & Suzuki, K. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85782 · Cited by 342
Activated T Lymphocytes are Essential Drivers of Pathological Remodeling in Ischemic Heart Failure
Bansal, S. S., Ismahil, M. A., Goel, M., Patel, B., Hamid, T., Rokosh, G., & Prabhu, S. D. (2017) · Circulation: Heart Failure · doi:10.1161/circheartfailure.116.003688 · Cited by 323
Regulatory T cells ameliorate cardiac remodeling after myocardial infarction
Tang, T.-T., Yuan, J., Zhu, Z.-F., Zhang, W.-C., Xiao, H., Xia, N., Yan, X.-X., Nie, S.-F., Liu, J., Zhou, S.-F., et al. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-011-0232-6 · Cited by 318
Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis
Ng, B., Dong, J., D’Agostino, G., Viswanathan, S., Widjaja, A. A., Lim, W.-W., Ko, N. S. J., Tan, J., Chothani, S. P., Huang, B., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw1237 · Cited by 314
Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis After Myocardial Infarction
Sreejit, G., Abdel-Latif, A., Athmanathan, B., Annabathula, R., Dhyani, A., Noothi, S. K., Quaife-Ryan, G. A., Al-Sharea, A., Pernes, G., Dragoljevic, D., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.043833 · Cited by 310
Ali, S. R., Ranjbarvaziri, S., Talkhabi, M., Zhao, P., Subat, A., Hojjat, A., Kamran, P., Müller, A. M. S., Volz, K. S., Tang, Z., et al. (2014) · Circulation Research · doi:10.1161/circresaha.115.303794 · Cited by 309
Suetomi, T., Willeford, A., Brand, C. S., Cho, Y., Ross, R. S., Miyamoto, S., & Brown, J. H. (2018) · Circulation · doi:10.1161/circulationaha.118.034621 · Cited by 304
CAR T cells: Continuation in a revolution of immunotherapy
Singh, A. K., & McGuirk, J. P. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30823-x · Cited by 303
Laroumanie, F., Douin-Echinard, V., Pozzo, J., Lairez, O., Tortosa, F., Vinel, C., Delage, C., Calise, D., Dutaur, M., Parini, A., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.007101 · Cited by 292
McLellan, M. A., Skelly, D. A., Dona, M. S. I., Squiers, G. T., Farrugia, G. E., Gaynor, T. L., Cohen, C. D., Pandey, R., Diep, H., Vinh, A., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.045115 · Cited by 287
Anti‐inflammatory therapies in myocardial infarction: failures, hopes and challenges
Huang, S., & Frangogiannis, N. G. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14155 · Cited by 282
Widjaja, A. A., Singh, B. K., Adami, E., Viswanathan, S., Dong, J., D’Agostino, G. A., Ng, B., Lim, W. W., Tan, J., Paleja, B. S., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.002 · Cited by 278
Left Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure
Nevers, T., Salvador, A. M., Grodecki-Pena, A., Knapp, A., Velázquez, F., Aronovitz, M., Kapur, N. K., Karas, R. H., Blanton, R. M., & Alcaide, P. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.115.002225 · Cited by 274
Cytosolic DNA Sensing Promotes Macrophage Transformation and Governs Myocardial Ischemic Injury
Cao, D. J., Schiattarella, G. G., Villalobos, E., Jiang, N., May, H. I., Li, T., Chen, Z. J., Gillette, T. G., & Hill, J. A. (2018) · Circulation · doi:10.1161/circulationaha.117.031046 · Cited by 272
Kaur, H., Takefuji, M., Ngai, C. Y., Carvalho, J., Bayer, J., Wietelmann, A., Poetsch, A., Hoelper, S., Conway, S. J., Möllmann, H., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308643 · Cited by 259
Han, J., Kim, Y. S., Lim, M.-Y., Kim, H. Y., Kong, S., Kang, M., Choo, Y. W., Jun, J. H., Ryu, S., Jeong, H.-Y., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b09107 · Cited by 258
Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction
Sager, H. B., Heidt, T., Hulsmans, M., Dutta, P., Courties, G., Sebas, M., Wojtkiewicz, G. R., Tricot, B., Iwamoto, Y., Sun, Y., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016160 · Cited by 253
Obligatory Role for B Cells in the Development of Angiotensin II–Dependent Hypertension
Chan, C. T., Sobey, C. G., Lieu, M., Ferens, D., Kett, M. M., Diep, H., Kim, H. A., Krishnan, S. M., Lewis, C. V., Salimova, E., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05779 · Cited by 243
The Macrophage in Cardiac Homeostasis and Disease
Lavine, K. J., Pinto, A. R., Epelman, S., Kopecky, B. J., Clemente-Casares, X., Godwin, J., Rosenthal, N., & Kovacic, J. C. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.2149 · Cited by 234
Structure-based decoupling of the pro- and anti-inflammatory functions of interleukin-10
Saxton, R. A., Tsutsumi, N., Su, L. L., Abhiraman, G. C., Mohan, K., Henneberg, L. T., Aduri, N. G., Gati, C., & Garcia, K. C. (2021) · Science · doi:10.1126/science.abc8433 · Cited by 232
Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure
Nevers, T., Salvador, A. M., Velazquez, F., Ngwenyama, N., Carrillo-Salinas, F. J., Aronovitz, M., Blanton, R. M., & Alcaide, P. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20161791 · Cited by 226
Villari, B., Campbell, S. E., Hess, O. M., Mall, G., Vassalli, G., Weber, K. T., & Krayenbuehl, H. P. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90560-n · Cited by 223
Treatment of Advanced Leukemia in Mice with mRNA Engineered T Cells
Barrett, D. M., Zhao, Y., Liu, X., Jiang, S., Carpenito, C., Kalos, M., Carroll, R. G., June, C. H., & Grupp, S. A. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.070 · Cited by 220
Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities
Andreadou, I., Cabrera-Fuentes, H. A., Devaux, Y., Frangogiannis, N. G., Frantz, S., Guzik, T., Liehn, E. A., Gomes, C. P. C., Schulz, R., & Hausenloy, D. J. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz050 · Cited by 213
Verma, S. K., Krishnamurthy, P., Barefield, D., Singh, N., Gupta, R., Lambers, E., Thal, M., Mackie, A., Hoxha, E., Ramirez, V., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.112185 · Cited by 207
Frantz, S., Hu, K., Adamek, A., Wolf, J., Sallam, A., KG Maier, S., Lonning, S., Ling, H., Ertl, G., & Bauersachs, J. (2008) · Basic Research in Cardiology · doi:10.1007/s00395-008-0739-7 · Cited by 201
T cell costimulation blockade blunts pressure overload-induced heart failure
Kallikourdis, M., Martini, E., Carullo, P., Sardi, C., Roselli, G., Greco, C. M., Vignali, D., Riva, F., Ormbostad Berre, A. M., Stølen, T. O., et al. (2017) · Nature Communications · doi:10.1038/ncomms14680 · Cited by 199
Abdullah, C. S., Alam, S., Aishwarya, R., Miriyala, S., Bhuiyan, M. A. N., Panchatcharam, M., Pattillo, C. B., Orr, A. W., Sadoshima, J., Hill, J. A., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37862-3 · Cited by 193
Choo, E. H., Lee, J.-H., Park, E.-H., Park, H. E., Jung, N.-C., Kim, T.-H., Koh, Y.-S., Kim, E., Seung, K.-B., Park, C., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.023106 · Cited by 190
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
Nagaraju, C. K., Robinson, E. L., Abdesselem, M., Trenson, S., Dries, E., Gilbert, G., Janssens, S., Van Cleemput, J., Rega, F., Meyns, B., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.02.049 · Cited by 187
Okada, H., Takemura, G., Kosai, K.-I., Li, Y., Takahashi, T., Esaki, M., Yuge, K., Miyata, S., Maruyama, R., Mikami, A., et al. (2005) · Circulation · doi:10.1161/01.cir.0000165066.71481.8e · Cited by 185
Epicardial YAP/TAZ orchestrate an immunosuppressive response following myocardial infarction
Ramjee, V., Li, D., Manderfield, L. J., Liu, F., Engleka, K. A., Aghajanian, H., Rodell, C. B., Lu, W., Ho, V., Wang, T., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88759 · Cited by 181
Self-citationChung, E. S., Miller, L., Patel, A. N., Anderson, R. D., Mendelsohn, F. O., Traverse, J., Silver, K. H., Shin, J., Ewald, G., Farr, M. J., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv254 · Cited by 178
Cardiac mast cells: the centrepiece in adverse myocardial remodelling
Levick, S. P., Melendez, G. C., Plante, E., McLarty, J. L., Brower, G. L., & Janicki, J. S. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq272 · Cited by 176
Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses
Rieckmann, M., Delgobo, M., Gaal, C., Büchner, L., Steinau, P., Reshef, D., Gil-Cruz, C., Horst, E. N. T., Kircher, M., Reiter, T., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123859 · Cited by 176
Macrophage activation and polarization in post-infarction cardiac remodeling
Gombozhapova, A., Rogovskaya, Y., Shurupov, V., Rebenkova, M., Kzhyshkowska, J., Popov, S. V., Karpov, R. S., & Ryabov, V. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0322-3 · Cited by 175
Myocardial Fibrosis in Transforming Growth Factor β1Heterozygous Mice
Brooks, W. W., & Conrad, C. H. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1065 · Cited by 174
Clearance of senescent cells during cardiac ischemia–reperfusion injury improves recovery
Dookun, E., Walaszczyk, A., Redgrave, R., Palmowski, P., Tual‐Chalot, S., Suwana, A., Chapman, J., Jirkovsky, E., Donastorg Sosa, L., Gill, E., et al. (2020) · Aging Cell · doi:10.1111/acel.13249 · Cited by 173
Anti-Inflammatory Treatment With Colchicine in Stable Chronic Heart Failure
Deftereos, S., Giannopoulos, G., Panagopoulou, V., Bouras, G., Raisakis, K., Kossyvakis, C., Karageorgiou, S., Papadimitriou, C., Vastaki, M., Kaoukis, A., et al. (2014) · JACC: Heart Failure · doi:10.1016/j.jchf.2013.11.006 · Cited by 169
de Sostoa, J., Fajardo, C. A., Moreno, R., Ramos, M. D. B., Farrera-Sal, M., & Alemany, R. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0505-4 · Cited by 167
Schmidt, M., Lamberts, M., Olsen, A.-M. S., Fosbøll, E., Niessner, A., Tamargo, J., Rosano, G., Agewall, S., Kaski, J. C., Kjeldsen, K., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv505 · Cited by 164
Vasconcelos, D. P., Costa, M. M., Amaral, I. F., Barbosa, M. A., Águas, A. P., & Barbosa, J. N. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.035 · Cited by 164
Mouton, A. J., Ma, Y., Rivera Gonzalez, O. J., Daseke, M. J., Flynn, E. R., Freeman, T. C., Garrett, M. R., DeLeon-Pennell, K. Y., & Lindsey, M. L. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0715-4 · Cited by 163
Myocardial Interstitial Fibrosis in Nonischemic Heart Disease, Part 3/4
Díez, J., González, A., & Kovacic, J. C. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.019 · Cited by 156
Hu, P., Liu, J., Zhao, J., Wilkins, B. J., Lupino, K., Wu, H., & Pei, L. (2018) · Genes & Development · doi:10.1101/gad.316802.118 · Cited by 152
Colchicine in cardiac disease: a systematic review and meta-analysis of randomized controlled trials
Verma, S., Eikelboom, J. W., Nidorf, S. M., Al-Omran, M. A., Gupta, N., Teoh, H., & Friedrich, J. O. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0068-3 · Cited by 151
Russo, I., Cavalera, M., Huang, S., Su, Y., Hanna, A., Chen, B., Shinde, A. V., Conway, S. J., Graff, J. M., & Frangogiannis, N. G. (2019) · Circulation Research · doi:10.1161/circresaha.118.314438 · Cited by 148
Dai, Z., Aoki, T., Fukumoto, Y., & Shimokawa, H. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.06.009 · Cited by 147
Resident fibroblast expansion during cardiac growth and remodeling
Ivey, M. J., Kuwabara, J. T., Pai, J. T., Moore, R. E., Sun, Z., & Tallquist, M. D. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.11.012 · Cited by 146
González‐Rosa, J. M., Peralta, M., & Mercader, N. (2012) · Developmental Biology · doi:10.1016/j.ydbio.2012.07.007 · Cited by 145
Eosinophils improve cardiac function after myocardial infarction
Liu, J., Yang, C., Liu, T., Deng, Z., Fang, W., Zhang, X., Li, J., Huang, Q. M., Liu, C., Wang, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19297-5 · Cited by 145
View from the heart: cardiac fibroblasts in development, scarring and regeneration
Furtado, M. B., Nim, H. T., Boyd, S. E., & Rosenthal, N. A. (2016) · Development · doi:10.1242/dev.120576 · Cited by 144
Shimojo, N., Hashizume, R., Kanayama, K., Hara, M., Suzuki, Y., Nishioka, T., Hiroe, M., Yoshida, T., & Imanaka‐Yoshida, K. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06004 · Cited by 137
Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA‐salt hypertensive rats
Mirkovic, S., Seymour, A. L., Fenning, A. S., Strachan, A. J., Margolin, S. B., Taylor, S. M., & Brown, L. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704539 · Cited by 129
Błyszczuk, P., Kania, G., Dieterle, T., Marty, R. R., Valaperti, A., Berthonneche, C., Pedrazzini, T., Berger, C. T., Dirnhofer, S., Matter, C. M., et al. (2009) · Circulation Research · doi:10.1161/circresaha.109.199802 · Cited by 128
Smith, S. C., & Allen, P. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9131 · Cited by 126
Janicki, J., Brower, G. L., Gardner, J. M., Forman, M. F., STEWARTJR, J., Murray, D., & Chancey, A. L. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.10.020 · Cited by 124
The complement system in ischemic heart disease.
Yasuda, M., Takeuchi, K., Hiruma, M., Iida, H., Tahara, A., Itagane, H., Toda, I., Akioka, K., Teragaki, M., & Oku, H. (1990) · Circulation · doi:10.1161/01.cir.81.1.156 · Cited by 124
Prattichizzo, F., Nigris, V. D., Micheloni, S., Sala, L. L., & Ceriello, A. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13488 · Cited by 124
Neutrophil proteome shifts over the myocardial infarction time continuum
Daseke, M. J., Valerio, F. M., Kalusche, W. J., Ma, Y., DeLeon‐Pennell, K. Y., & Lindsey, M. L. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0746-x · Cited by 124
Natural killer cells in inflammatory heart disease
Ong, S., Rose, N. R., & Čiháková, D. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.11.010 · Cited by 123
Crosstalk between TGF-β and WNT signalling pathways during cardiac fibrogenesis
Działo, E., Tkacz, K., & Błyszczuk, P. (2018) · Acta Biochimica Polonica · doi:10.18388/abp.2018_2635 · Cited by 122
Toldo, S. A., Mezzaroma, E., Tassell, B. W. V., Farkas, D., Marchetti, C., Voelkel, N. F., & Abbate, A. (2012) · Experimental Physiology · doi:10.1113/expphysiol.2012.069831 · Cited by 120
Neutrophil signaling during myocardial infarction wound repair
Daseke, M. J., Chalise, U., Becirovic‐Agic, M., Salomon, J., Cook, L. M., Case, A. J., & Lindsey, M. L. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109816 · Cited by 118
Zhang, W., Chancey, A. L., Tzeng, H.-P., Zhou, Z., Lavine, K. J., Gao, F., Sivasubramanian, N., Barger, P. M., & Mann, D. L. (2011) · Circulation · doi:10.1161/circulationaha.111.052399 · Cited by 115
Ayach, B., Yoshimitsu, M., Dawood, F., Sun, M., Arab, S., Chen, M., Higuchi, K., Siatskas, C., Lee, P. C., Lim, H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510997103 · Cited by 115
Natural Killer Cells Limit Cardiac Inflammation and Fibrosis by Halting Eosinophil Infiltration
Ong, S., Ligons, D. L., Barin, J. G., Wu, L., Talor, M. V., Diny, N. L., Fontes, J. A., Gebremariam, E., Kass, D. A., Rose, N. R., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.11.023 · Cited by 115
Tissue-resident macrophages regulate lymphatic vessel growth and patterning in the developing heart
Cahill, T. J., Sun, X., Ravaud, C., del Campo, C. V., Klaourakis, K., Lupu, I.-E., Lord, A. M., Browne, C., Jacobsen, S. E. W., Greaves, D. R., et al. (2021) · Development · doi:10.1242/dev.194563 · Cited by 113
Hu, D., Cui, Y.-X., Wu, M., Li, L., Su, L., Lian, Z., & Chen, H. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00097.2020 · Cited by 112
Innate Immune Receptors, Key Actors in Cardiovascular Diseases
Jaén, R. I., Val‐Blasco, A., Prieto, P., Fernández, M. G., Smani, T., Lopez-Sendon, J. L., Delgado, C., Boscá, L., & Fernández‐Velasco, M. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.03.015 · Cited by 111
Laverman, P., van der Geest, T., Terry, S. Y. A., Gerrits, D., Walgreen, B., Helsen, M. M. A., Nayak, T. K., Freimoser–Grundschober, A., Waldhauer, I., Hosse, R. J., et al. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.152959 · Cited by 109
Rainer, P. P., Hao, S. B., Vanhoutte, D., Lee, D. I., Koitabashi, N., Molkentin, J. D., & Kass, D. A. (2014) · Circulation Research · doi:10.1161/circresaha.114.302653 · Cited by 108
Cross-Priming Dendritic Cells Exacerbate Immunopathology After Ischemic Tissue Damage in the Heart
Forte, E., Perkins, B., Sintou, A., Kalkat, H., Papanikolaou, A., Jenkins, C., Alsubaie, M., Chowdhury, R. A., Duffy, T. M., Skelly, D. A., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.044581 · Cited by 104
Siebermair, J., Köhler, M. I., Kupusović, J., Nekolla, S. G., Kessler, L., Ferdinandus, J., Guberina, N., Stuschke, M., Grafe, H., Siveke, J. T., et al. (2020) · Journal of Nuclear Cardiology · doi:10.1007/s12350-020-02307-w · Cited by 103
CXCR3 regulates CD4+ T cell cardiotropism in pressure overload–induced cardiac dysfunction
Ngwenyama, N., Salvador, A. M., Velázquez, F., Nevers, T. A., Levy, A. M., Aronovitz, M. J., Luster, A. D., Huggins, G. S., & Alcaide, P. (2019) · JCI Insight · doi:10.1172/jci.insight.125527 · Cited by 102
Extracellular Matrix in Ischemic Heart Disease, Part 4/4
Frangogiannis, N. G., & Kovacic, J. C. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.020 · Cited by 97
The Immune System in Viral Myocarditis
Knowlton, K. U., & Badorff, C. (1999) · Circulation Research · doi:10.1161/01.res.85.6.559 · Cited by 91
Ichihara, S., Senbonmatsu, T., Price, E., Ichiki, T., Gaffney, F. A., & Inagami, T. (2002) · Circulation · doi:10.1161/01.cir.0000033826.52681.37 · Cited by 89
Toor, I. S., Rückerl, D., Mair, I., Ainsworth, R., Meloni, M., Spiroski, A., Bénézech, C., Felton, J. M., Thomson, A. J. W., Caporali, A., et al. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.05.005 · Cited by 89
Targeting senescent cells to attenuate cardiovascular disease progression
Song, P., Zhao, Q., & Zou, M. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101072 · Cited by 86
Cytokines as Emerging Targets in the Treatment of Heart Failure
Baumgarten, G., Knuefermann, P., & Mann, D. L. (2000) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(00)00063-3 · Cited by 85
Cheung, C. C., Constantine, M., Ahmadi, A., Shiau, C., & Chen, L. Y. C. (2017) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2017.04.002 · Cited by 78
Senolytic Agent Navitoclax Inhibits Angiotensin II-Induced Heart Failure in Mice
Jia, K., Dai, Y., Liu, A., Li, X., Wu, L., Lu, L., Bao, Y., & Jin, Q. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000878 · Cited by 74
García‐Rivas, G., Castillo, E. C., González-Gil, A. M., Maravillas‐Montero, J. L., Brunck, M. E. G., Torres‐Quintanilla, A., Elizondo‐Montemayor, L., & Torre‐Amione, G. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12744 · Cited by 72
The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice
Yamazaki, T., Yamashita, N., Izumi, Y., Nakamura, Y., Shiota, M., Hanatani, A., Shimada, K., Muro, T., Iwao, H., & Yoshiyama, M. (2011) · Hypertension Research · doi:10.1038/hr.2011.139 · Cited by 71
Long‐term administration of pirfenidone improves cardiac function inmdxmice
van Erp, C., Irwin, N. G., & Hoey, A. J. (2006) · Muscle & Nerve · doi:10.1002/mus.20590 · Cited by 71
Ngwenyama, N., Kirabo, A., Aronovitz, M. J., Velázquez, F., Carrillo-Salinas, F. J., Salvador, A. M., Nevers, T. A., Amarnath, V., Tai, A., Blanton, R. M., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.051889 · Cited by 71
Influenza infection and heart failure—vaccination may change heart failure prognosis?
Kadoglou, N. P. E., Bracke, F. A. L. E., Simmers, T., Tsiodras, S., & Parissis, J. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9614-7 · Cited by 64
Lewis, G. A., Schelbert, E. B., Naish, J. H., Bedson, E., Dodd, S. R., Eccleson, H., Clayton, D., Duran-Jimenez, B., McDonagh, T. A., Williams, S. G., et al. (2019) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-019-06876-y · Cited by 62
Colchicine in ischemic heart disease: the good, the bad and the ugly
D’Amario, D., Cappetta, D., Cappannoli, L., Princi, G., Migliaro, S., Diana, G., Chouchane, K., Borovac, J. A., Restivo, A., Arcudi, A., et al. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01828-9 · Cited by 62
Forte, E., Panahi, M., Baxan, N., Ng, F. S., Boyle, J. J., Branca, J. A., Bedard, O., Hasham, M. G., Benson, L., Harding, S. E., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15937 · Cited by 59
T Cells Engineered with a Cytomegalovirus-Specific Chimeric Immunoreceptor
Full, F., Lehner, M., Thonn, V., Goetz, G., Scholz, B., Kaufmann, K. B., Mach, M., Abken, H., Holter, W., & Ensser, A. (2010) · Journal of Virology · doi:10.1128/jvi.02117-09 · Cited by 54
Role of interleukin‐15 in cardiovascular diseases
Guo, L., Liu, M.-F., Huang, J., Li, J., Jiang, J., & Wang, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15296 · Cited by 54
Windisch, P. Y., Zwahlen, D. R., Giesel, F. L., Scholz, E., Lugenbiel, P., Debus, J., Haberkorn, U., & Adeberg, S. (2021) · EJNMMI Research · doi:10.1186/s13550-021-00761-2 · Cited by 54
Ma, F., Feng, J., Zhang, C., Li, Y., Qi, G., Li, H., Wu, Y., Fu, Y., Zhao, Y., Chen, H., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301522 · Cited by 53
Schmidt, M., Lamberts, M., Olsen, A. S., Fosbøl, E. L., Niessner, A., Tamargo, J. L., Rosano, G. M. C., Agewall, S., Kaski, J. C., Kjeldsen, K. P., et al. (2016) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvv054 · Cited by 49
Different DOACs Control Inflammation in Cardiac Ischemia-Reperfusion Differently
Gadi, I., Fatima, S., Elwakiel, A., Nazir, S., Al‐Dabet, M. M., Rana, R., Bock, F. M., Manoharan, J., Gupta, D., Biemann, R., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.317219 · Cited by 42
Crnkovic, M. Z., Kania, G., Jaźwa, A., Czepiel, M., Wijnen, W. J., Czyż, J., Müller‐Edenborn, B., Vdovenko, D., Lindner, D., Gil‐Cruz, C., et al. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0766-6 · Cited by 30
Immune Regulation of Tissue Repair and Regeneration via miRNAs—New Therapeutic Target
Piotto, C., Julier, Z., & Martino, M. M. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00098 · Cited by 29
Emmens, R. W., Wouters, D., Zeerleder, S. S., van Ham, S. M., Niessen, H. W. M., & Krijnen, P. A. J. (2016) · Translational research · doi:10.1016/j.trsl.2016.10.005 · Cited by 25
Hoffmann, D. B., Fraccarollo, D., Galuppo, P., Frantz, S., Bauersachs, J. K., & Tillmanns, J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248196 · Cited by 20
Exosomes: Outlook for Future Cell-Free Cardiovascular Disease Therapy
Barani, B., Rajasingh, S., & Rajasingh, J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4397-0_19 · Cited by 18
Predicting Dangerous Rides in CAR T Cells: Bridging the Gap between Mice and Humans
Ruella, M., & June, C. H. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.05.005 · Cited by 17
Immune cell dilemma in ischemic cardiomyopathy: to heal or not to heal
Nehra, S., Gumina, R. J., & Bansal, S. S. (2020) · Current Opinion in Physiology · doi:10.1016/j.cophys.2020.09.002 · Cited by 10
Cited by
CAR T cells produced in vivo to treat cardiac injury
Rurik, J. G., Tombácz, I., Yadegari, A., Méndez Fernández, P. O., Shewale, S. V., Li, L., Kimura, T., Soliman, O. Y., Papp, T. E., Tam, Y. K., et al. (2022) · Science · doi:10.1126/science.abm0594 · Cited by 1,400
Self-citationMyocardial ischemia-reperfusion injury and the influence of inflammation
Algoet, M., Janssens, S., Himmelreich, U., Gsell, W., Pusovnik, M., Van den Eynde, J., & Oosterlinck, W. (2023) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2022.02.005 · Cited by 545
Engineered cellular immunotherapies in cancer and beyond
Finck, A. V., Blanchard, T., Roselle, C. P., Golinelli, G., & June, C. H. (2022) · Nature Medicine · doi:10.1038/s41591-022-01765-8 · Cited by 269
Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments
Li, G., Wan, Y., Jiao, A., Jiang, K., Cui, G., Tang, J., Yu, S., Hu, Z., Zhao, S., Yi, Z., et al. (2025) · Med Research · doi:10.1002/mdr2.70007 · Cited by 63
Metadata
- Authors
- Rurik, J. G., Aghajanian, H., & Epstein, J. A.
- Venue
- Circulation Research
- Published
- 2021-05-28
- Volume
- 128
- Issue
- 11
- Pages
- 1766-1779
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W3164268445
- Cited by
- 265
- References
- 191
- FWCI
- 25.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.